참고문헌 (133)

1. 1. World Health Organization WHO Director-General's Remarks at the Media Briefing on 2019-nCoV on 11 February 2020 ( 2020 ). 

2. 2. World Health Organization Coronavirus Disease (COVID-19) Situation Report ？ 163. ( 2020 ). 

3. 3. Peiris JS Chu CM Cheng VC Chan KS Hung IF Poon LL . Group USS. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study . Lancet. ( 2003 ) 361 : 1767 ？ 72 . 10.1016/S0140-6736(03)13412-5 12781535 

   상세보기

4. 4. Zumla A Hui DS Perlman S . Middle East respiratory syndrome . Lancet. ( 2015 ) 386 : 995 ？ 1007 . 10.1016/S0140-6736(15)60454-8 26049252 

   상세보기

5. 5. Prompetchara E Ketloy C Palaga T . Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic . Asian Pac J Allergy Immunol. ( 2020 ) 38 : 1 ？ 9 . 10.12932/AP-200220-0772 32105090 

   

6. 6. Chan JF Lau SK To KK Cheng VC Woo PC Yuen KY . Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease . Clin Microbiol Rev. ( 2015 ) 28 : 465 ？ 522 . 10.1128/CMR.00102-14 25810418 

   상세보기

7. 7. To KK Tsang OT Leung WS Tam AR Wu TC Lung DC . Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study . Lancet Infect Dis . ( 2020 ) 20 : 565 ？ 74 . 10.1016/S1473-3099(20)30196-1 32213337 

   상세보기

8. 8. The Who Mers-Cov Research Group State of knowledge and data gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in humans . PLoS Curr . ( 2013 ) 

9. 9. Wang D Hu B Hu C Zhu F Liu X Zhang J . Clinical characteristics of 138 hospitalised patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China . JAMA . ( 2020 ) 323 : 1061 ？ 9 . 10.1001/jama.2020.1585 32031570 

   상세보기

10. 10. Guan WJ Ni ZY Hu Y Liang WH Ou CQ He JX . China Medical Treatment Expert Group for, clinical characteristics of coronavirus disease 2019 in China . N Engl J Med . ( 2020 ) 382 : 1708 ？ 20 . 10.1056/NEJMoa2002032 32109013 

    상세보기

11. 11. Wu JT Leung K Leung GM . Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study . Lancet. ( 2020 ) 395 : 689 ？ 97 . 10.1016/S0140-6736(20)30260-9 32014114 

    상세보기

12. 12. Xiao K Zhai J Feng Y Zhou N Zhang X Zou JJ . Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins . Nature . ( 2020 ) 583 : 286 ？ 9 . 10.1038/s41586-020-2313-x 32380510 

    상세보기

13. 13. Ruan Q Yang K Wang W Jiang L Song J Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China . Intensive Care Med. ( 2020 ) 46 : 846 ？ 8 . 10.1007/s00134-020-05991-x 32125452 

    상세보기

14. 14. Wu Z McGoogan JM . Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention . JAMA . ( 2020 ) 323 : 1239 ？ 42 . 10.1001/jama.2020.2648 32091533 

    상세보기

15. 15. Wu A Peng Y Huang B Ding X Wang X Niu P . Genome composition and divergence of the novel Coronavirus (2019-nCoV) originating in China . Cell Host Microbe. ( 2020 ) 27 : 325 ？ 8 . 10.1016/j.chom.2020.02.001 32035028 

    상세보기

16. 16. Hamming I Timens W Bulthuis ML Lely AT Navis G van Goor H . Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis . J Pathol. ( 2004 ) 203 : 631 ？ 7 . 10.1002/path.1570 15141377 

    상세보기

17. 17. Raj VS Mou H Smits SL Dekkers DH Muller MA Dijkman R . Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC . Nature. ( 2013 ) 495 : 251 ？ 4 . 10.1038/nature12005 23486063 

    상세보기

18. 18. Lu R Zhao X Li J Niu P Yang B Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding . Lancet. ( 2020 ) 395 : 565 ？ 74 . 10.1016/S0140-6736(20)30251-8 32007145 

    상세보기

19. 19. Zhou P Yang XL Wang XG Hu B Zhang L Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin . Nature. ( 2020 ) 579 : 270 ？ 3 . 10.1038/s41586-020-2012-7 32015507 

    상세보기

20. 20. Benvenuto D Giovanetti M Ciccozzi A Spoto S Angeletti S Ciccozzi M . The 2019-new coronavirus epidemic: evidence for virus evolution . J Med Virol. ( 2020 ) 92 : 455 ？ 9 . 10.1002/jmv.25688 31994738 

    상세보기

21. 21. World Health Organization Summary of Probable SARS Cases With Onset of Illness From 1 November 2002 to 31 July 2003 ( 2003 ). 

22. 22. Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention . [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China] . Zhonghua Liu Xing Bing Xue Za Zhi . ( 2020 ) 41 : 145 ？ 51 . 10.3760/cma.j.issn.0254-6450.2020.02.003 32064853 

    

23. 23. Granados A Peci A McGeer A Gubbay JB . Influenza and rhinovirus viral load and disease severity in upper respiratory tract infections . J Clin Virol. ( 2017 ) 86 : 14 ？ 19 . 10.1016/j.jcv.2016.11.008 27893998 

    상세보기

24. 24. Wang WK Chen SY Liu IJ Kao CL Chen HL Chiang BL . Severe acute respiratory syndrome research group of the National Taiwan University College of Medicine, temporal relationship of viral load, ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with severe acute respiratory syndrome . Clin Infect Dis. ( 2004 ) 39 : 1071 ？ 5 . 10.1086/423808 15472864 

    상세보기

25. 25. Chen W Xu Z Mu J Yang L Gan H Mu F . Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection . J Med Microbiol. ( 2004 ) 53 : 435 ？ 38 . 10.1099/jmm.0.45561-0 15096554 

    상세보기

26. 26. Hung IF Cheng VC Wu AK Tang BS Chan KH Chu CM . Viral loads in clinical specimens and SARS manifestations . Emerg Infect Dis. ( 2004 ) 10 : 1550 ？ 7 . 10.3201/eid1009.040058 15498155 

    상세보기

27. 27. Chu CM Poon LL Cheng VC Chan KS Hung IF Wong MM . Initial viral load and the outcomes of SARS . CMAJ. ( 2004 ) 171 : 1349 ？ 52 . 10.1503/cmaj.1040398 15557587 

    상세보기

28. 28. Snijder EJ van der Meer Y Zevenhoven-Dobbe J Onderwater JJ van der Meulen J Koerten HK . Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex . J Virol. ( 2006 ) 80 : 5927 ？ 40 . 10.1128/JVI.02501-05 16731931 

    상세보기

29. 29. Bouvet M Debarnot C Imbert I Selisko B Snijder EJ Canard B . In vitro reconstitution of SARS-coronavirus mRNA cap methylation . PLoS Pathog. ( 2010 ) 6 : e1000863 . 10.1371/journal.ppat.1000863 20421945 

    상세보기

30. 30. Hu W Yen YT Singh S Kao CL Wu-Hsieh BA . SARS-CoV regulates immune function-related gene expression in human monocytic cells . Viral Immunol. ( 2012 ) 25 : 277 ？ 88 . 10.1089/vim.2011.0099 22876772 

    상세보기

31. 31. Connor RF Roper RL . Unique SARS-CoV protein nsp1: bioinformatics, biochemistry and potential effects on virulence . Trends Microbiol. ( 2007 ) 15 : 51 ？ 3 . 10.1016/j.tim.2006.12.005 17207625 

    상세보기

32. 32. Cheng VC Lau SK Woo PC Yuen KY . Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection . Clin Microbiol Rev. ( 2007 ) 20 : 660 ？ 94 . 10.1128/CMR.00023-07 17934078 

    상세보기

33. 33. de Wit E van Doremalen N Falzarano D Munster VJ . SARS and MERS: recent insights into emerging coronaviruses . Nat Rev Microbiol. ( 2016 ) 14 : 523 ？ 34 . 10.1038/nrmicro.2016.81 27344959 

    상세보기

34. 34. Channappanavar R Perlman S . Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology . Semin Immunopathol. ( 2017 ) 39 : 529 ？ 39 . 10.1007/s00281-017-0629-x 28466096 

    상세보기

35. 35. Law HK Cheung CY Ng HY Sia SF Chan YO Luk W . Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells . Blood. ( 2005 ) 106 : 2366 ？ 74 . 10.1182/blood-2004-10-4166 15860669 

    상세보기

36. 36. Cheung CY Poon LL Ng IH Luk W Sia SF Wu MH . Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro : possible relevance to pathogenesis . J Virol. ( 2005 ) 79 : 7819 ？ 26 . 10.1128/JVI.79.12.7819-7826.2005 15919935 

    상세보기

37. 37. Broxmeyer HE Sherry B Cooper S Lu L Maze R Beckmann MP . Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression . J Immunol. ( 1993 ) 150 : 3448 ？ 58 . 7682242 

38. 38. Herold S Steinmueller M. von Wulffen W Cakarova L Pinto R Pleschka S . Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand . J Exp Med. ( 2008 ) 205 : 3065 ？ 77 . 10.1084/jem.20080201 19064696 

    상세보기

39. 39. Boonnak K Vogel L Feldmann F Feldmann H Legge KL Subbarao K . Lymphopenia associated with highly virulent H5N1 virus infection due to plasmacytoid dendritic cell-mediated apoptosis of T cells . J Immunol. ( 2014 ) 192 : 5906 ？ 12 . 10.4049/jimmunol.1302992 24829418 

    상세보기

40. 40. Cameron MJ Ran L Xu L Danesh A Bermejo-Martin JF Cameron CM . Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome . J Virol. ( 2007 ) 81 : 8692 ？ 706 . 10.1128/JVI.00527-07 17537853 

    상세보기

41. 41. Hui DS Chan MC Wu AK Ng PC . Severe acute respiratory syndrome (SARS): epidemiology and clinical features . Postgrad Med J. ( 2004 ) 80 : 373 ？ 81 . 10.1136/pgmj.2004.020263 15254300 

    상세보기

42. 42. Wong CK Lam CW Wu AK Ip WK Lee NL Chan IH . Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome . Clin Exp Immunol. ( 2004 ) 136 : 95 ？ 103 . 10.1111/j.1365-2249.2004.02415.x 15030519 

    상세보기

43. 43. Huang KJ Su IJ Theron M Wu YC Lai SK Liu CC . An interferon-gamma-related cytokine storm in SARS patients . J Med Virol. ( 2005 ) 75 : 185 ？ 94 . 10.1002/jmv.20255 15602737 

    상세보기

44. 44. Li CK Wu H Yan H Ma S Wang L Zhang M . T cell responses to whole SARS coronavirus in humans . J Immunol. ( 2008 ) 181 : 5490 ？ 500 . 10.4049/jimmunol.181.8.5490 18832706 

    상세보기

45. 45. Mahallawi WH Khabour OF Zhang Q Makhdoum HM Suliman BA . MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile . Cytokine. ( 2018 ) 104 : 8 ？ 13 . 10.1016/j.cyto.2018.01.025 29414327 

    상세보기

46. 46. Lau SK Lau CC Chan KH Li CP Chen H Jin DY . Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment . J Gen Virol. ( 2013 ) 94 : 2679 ？ 90 . 10.1099/vir.0.055533-0 24077366 

    상세보기

47. 47. Zhou J Chu H Li C Wong BH Cheng ZS Poon VK . Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis . J Infect Dis. ( 2014 ) 209 : 1331 ？ 42 . 10.1093/infdis/jit504 24065148 

    상세보기

48. 48. Liu J Li S Liu J Liang B Wang X Wang H . Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients . EBioMedicine. ( 2020 ) 55 : 102763 . 10.1016/j.ebiom.2020.102763 32361250 

    상세보기

49. 49. Huang C Wang Y Li X Ren L Zhao J Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China . Lancet. ( 2020 ) 395 : 497 ？ 506 . 10.1016/S0140-6736(20)30183-5 31986264 

    상세보기

50. 50. Zhang Y Li J Zhan Y Wu L Yu X Zhang W . Analysis of serum cytokines in patients with severe acute respiratory syndrome . Infect Immun. ( 2004 ) 72 : 4410 ？ 5 . 10.1128/IAI.72.8.4410-4415.2004 15271897 

    상세보기

51. 51. Faure E Poissy J Goffard A Fournier C Kipnis E Titecat M . Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside? PLoS ONE. ( 2014 ) 9 : e88716 . 10.1371/journal.pone.0088716 24551142 

    상세보기

52. 52. Yang Y Shen C Li J Yuan J Yang M Wang F Exuberant elevation of IP-10, MCP- 3 and IL-1ra during SARS-CoV-2 infection is associated with dis- ease severity and fatal outcome . medRxiv [Preprint] . ( 2020 ). 10.1101/2020.03.02.20029975 

    

53. 53. Li X Xu S Yu M Wang K Tao Y Zhou Y . Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan . J Allergy Clin Immunol . ( 2020 ) 146 : 110 ？ 118 . 10.1016/j.jaci.2020.04.006 32294485 

    상세보기

54. 54. Zhang S Gan J Chen BG Zheng D Zhang JG Lin RH . Dynamics of peripheral immune cells and their HLA-G and receptor expressions in a patient suffering from critical COVID-19 pneumonia to convalescence . Clin Transl Immunol. ( 2020 ) 9 : e1128 . 10.1002/cti2.1128 32399213 

    상세보기

55. 55. Han SN Meydani SN . Antioxidants, cytokines, and influenza infection in aged mice and elderly humans . J Infect Dis. ( 2000 ) 182 ( Suppl. 1 ): S74 ？ 80 . 10.1086/315915 10944487 

    상세보기

56. 56. Jiang Y Xu J Zhou C Wu Z Zhong S Liu J . Characterisation of cytokine/chemokine profiles of severe acute respiratory syndrome . Am J Respir Crit Care Med. ( 2005 ) 171 : 850 ？ 7 . 10.1164/rccm.200407-857OC 15657466 

    상세보기

57. 57. Ryzhakov G Lai CC Blazek K To KW Hussell T Udalova I . IL-17 boosts proinflammatory outcome of antiviral response in human cells . J Immunol. ( 2011 ) 187 : 5357 ？ 62 . 10.4049/jimmunol.1100917 21964025 

    상세보기

58. 58. Crowe CR Chen K Pociask DA Alcorn JF Krivich C Enelow RI . Critical role of IL-17RA in immunopathology of influenza infection . J Immunol. ( 2009 ) 183 : 5301 ？ 10 . 10.4049/jimmunol.0900995 19783685 

    상세보기

59. 59. Josset L Menachery VD Gralinski LE Agnihothram S Sova P Carter VS . Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus . mBio. ( 2013 ) 4 : e00165 ？ 13 . 10.1128/mBio.00165-13 23631916 

    상세보기

60. 60. Ichikawa A Kuba K Morita M Chida S Tezuka H Hara H . CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin . Am J Respir Crit Care Med. ( 2013 ) 187 : 65 ？ 77 . 10.1164/rccm.201203-0508OC 23144331 

    상세보기

61. 61. Totura AL Baric RS . SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon . Curr Opin Virol. ( 2012 ) 2 : 264 ？ 75 . 10.1016/j.coviro.2012.04.004 22572391 

    상세보기

62. 62. Frieman MB Chen J Morrison TE Whitmore A Funkhouser W Ward JM . SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism . PLoS Pathog. ( 2010 ) 6 : e1000849 . 10.1371/journal.ppat.1000849 20386712 

    상세보기

63. 63. Channappanavar R Fehr AR Vijay R Mack M Zhao J Meyerholz DK . Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice . Cell Host Microbe. ( 2016 ) 19 : 181 ？ 93 . 10.1016/j.chom.2016.01.007 26867177 

    상세보기

64. 64. Liu W Fontanet A Zhang PH Zhan L Xin ZT Baril L . Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome . J Infect Dis. ( 2006 ) 193 : 792 ？ 5 . 10.1086/500469 16479513 

    상세보기

65. 65. Tang F Quan Y Xin ZT Wrammert J Ma MJ Lv H . Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study . J Immunol. ( 2011 ) 186 : 7264 ？ 8 . 10.4049/jimmunol.0903490 21576510 

    상세보기

66. 66. Lee N Chan PK Ip M Wong E Ho J Ho C . Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome . J Clin Virol. ( 2006 ) 35 : 179 ？ 84 . 10.1016/j.jcv.2005.07.005 16112612 

    상세보기

67. 67. Zhang L Zhang F Yu W He T Yu J Yi CE . Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals . J Med Virol. ( 2006 ) 78 : 1 ？ 8 . 10.1002/jmv.20499 16299724 

    상세보기

68. 68. Liu L Wei Q Lin Q Fang J Wang H Kwok H . Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection . JCI Insight. ( 2019 ) 4 : e123158 . 10.1172/jci.insight.123158 30830861 

    상세보기

69. 69. Kong SL Chui P Lim B Salto-Tellez M . Elucidating the molecular physiopathology of acute respiratory distress syndrome in severe acute respiratory syndrome patients . Virus Res. ( 2009 ) 145 : 260 ？ 9 . 10.1016/j.virusres.2009.07.014 19635508 

    상세보기

70. 70. Page C Goicochea L Matthews K Zhang Y Klover P Holtzman MJ . Induction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infection . J Virol. ( 2012 ) 86 : 13334 ？ 49 . 10.1128/JVI.01689-12 23015710 

    상세보기

71. 71. Glaser R MacCallum RC Laskowski BF Malarkey WB Sheridan JF Kiecolt-Glaser JK . Evidence for a shift in the Th-1 to Th-2 cytokine response associated with chronic stress and aging . J Gerontol A Biol Sci Med Sci. ( 2001 ) 56 : M477 ？ 82 . 10.1093/gerona/56.8.M477 11487599 

    상세보기

72. 72. Kam YW Kien F Roberts A Cheung YC Lamirande EW Vogel L . Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro . Vaccine. ( 2007 ) 25 : 729 ？ 40 . 10.1016/j.vaccine.2006.08.011 17049691 

    상세보기

73. 73. Cummings DA Schwartz IB Billings L Shaw LB Burke DS . Dynamic effects of antibody-dependent enhancement on the fitness of viruses . Proc Natl Acad Sci USA. ( 2005 ) 102 : 15259 ？ 64 . 10.1073/pnas.0507320102 16217017 

    상세보기

74. 74. Perlman S Dandekar AA . Immunopathogenesis of coronavirus infections: implications for SARS . Nat Rev Immunol. ( 2005 ) 5 : 917 ？ 27 . 10.1038/nri1732 16322745 

    상세보기

75. 75. Jaume M Yip MS Cheung CY Leung HL Li PH Kien F . Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcgammaR pathway . J Virol. ( 2011 ) 85 : 10582 ？ 97 . 10.1128/JVI.00671-11 21775467 

    상세보기

76. 76. Wan Y Shang J Sun S Tai W Chen J Geng Q . Molecular mechanism for antibody-dependent enhancement of coronavirus entry . J Virol. ( 2020 ) 94 : e02015 - 19 . 10.1128/JVI.02015-19 31826992 

    상세보기

77. 77. Channappanavar R Fett C Zhao J Meyerholz DK Perlman S . Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection . J Virol. ( 2014 ) 88 : 11034 ？ 44 . 10.1128/JVI.01505-14 25056892 

    상세보기

78. 78. Zhao J Zhao J Van Rooijen N Perlman S . Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice . PLoS Pathog. ( 2009 ) 5 : e1000636 . 10.1371/journal.ppat.1000636 19851468 

    상세보기

79. 79. Zhao J Zhao J Perlman S . T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice . J Virol. ( 2010 ) 84 : 9318 ？ 25 . 10.1128/JVI.01049-10 20610717 

    상세보기

80. 80. Zhao J Zhao J Mangalam AK Channappanavar R Fett C Meyerholz DK . Airway memory CD4(+) T cells mediate protective immunity against emerging respiratory coronaviruses . Immunity. ( 2016 ) 44 : 1379 ？ 91 . 10.1016/j.immuni.2016.05.006 27287409 

    상세보기

81. 81. Liu WJ Zhao M Liu K Xu K Wong G Tan W . T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV . Antiviral Res. ( 2017 ) 137 : 82 ？ 92 . 10.1016/j.antiviral.2016.11.006 27840203 

    상세보기

82. 82. Cui W Fan Y Wu W Zhang F Wang JY Ni AP . Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome . Clin Infect Dis. ( 2003 ) 37 : 857 ？ 9 . 10.1086/378587 12955652 

    상세보기

83. 83. Zhao J Zhao J Legge K Perlman S . Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice . J Clin Invest. ( 2011 ) 121 : 4921 ？ 30 . 10.1172/JCI59777 22105170 

    상세보기

84. 84. Yang Y Xiong Z Zhang S Yan Y Nguyen J Ng B . Bcl-xL inhibits T-cell apoptosis induced by expression of SARS coronavirus E protein in the absence of growth factors . Biochem J. ( 2005 ) 392 : 135 ？ 43 . 10.1042/BJ20050698 16048439 

    상세보기

85. 85. Al-Tawfiq JA Hinedi K Ghandour J Khairalla H Musleh S Ujayli A . Middle East respiratory syndrome coronavirus: a case-control study of hospitalised patients . Clin Infect Dis. ( 2014 ) 59 : 160 ？ 5 . 10.1093/cid/ciu226 24723278 

    상세보기

86. 86. Chu H Zhou J Wong BH Li C Chan JF Cheng ZS . Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways . J Infect Dis. ( 2016 ) 213 : 904 ？ 14 . 10.1093/infdis/jiv380 26203058 

    상세보기

87. 87. Chu H Zhou J Wong BH Li C Cheng ZS Lin X . Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response . Virology. ( 2014 ) 454？455 : 197 ？ 205 . 10.1016/j.virol.2014.02.018 24725946 

    상세보기

88. 88. Tseng CT Perrone LA Zhu H Makino S Peters CJ . Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection . J Immunol. ( 2005 ) 174 : 7977 ？ 85 . 10.4049/jimmunol.174.12.7977 15944304 

    상세보기

89. 89. Chan JF Chan KH Choi GK To KK Tse H Cai JP . Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation . J Infect Dis. ( 2013 ) 207 : 1743 ？ 52 . 10.1093/infdis/jit123 23532101 

    상세보기

90. 90. van Doremalen N Miazgowicz KL Milne-Price S Bushmaker T Robertson S Scott D . Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4 . J Virol. ( 2014 ) 88 : 9220 ？ 32 . 10.1128/JVI.00676-14 24899185 

    상세보기

91. 91. Lambeir AM Durinx C Scharpe S De Meester I . Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, clinical aspects of the enzyme DPP IV . Crit Rev Clin Lab Sci . ( 2003 ) 40 : 209 ？ 94 . 10.1080/713609354 12892317 

    상세보기

92. 92. Zielecki F Weber M Eickmann M Spiegelberg L Zaki AM Matrosovich M . Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus . J Virol. ( 2013 ) 87 : 5300 ？ 4 . 10.1128/JVI.03496-12 23449793 

    상세보기

93. 93. Menachery VD Eisfeld AJ Schafer A Josset L Sims AC Proll S . Pathogenic influenza viruses and coronaviruses utilise similar and contrasting approaches to control interferon-stimulated gene responses . mBio. ( 2014 ) 5 : e01174 ？ 14 . 10.1128/mBio.01174-14 24846384 

    상세보기

94. 94. Kouzarides T . Chromatin modifications and their function . Cell . ( 2007 ) 128 : 693 ？ 705 . 10.1016/j.cell.2007.02.005 17320507 

    상세보기

95. 95. Channappanavar R Fehr AR Zheng J Wohlford-Lenane C Abrahante JE Mack M . IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes . J Clin Invest. ( 2019 ) 130 : 3625 ？ 39 . 10.1172/JCI126363 31355779 

    상세보기

96. 96. Zhao J Alshukairi AN Baharoon SA Ahmed WA Bokhari AA Nehdi AM . Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responses . Sci Immunol. ( 2017 ) 2 : eaan5393 . 10.1126/sciimmunol.aan5393 28778905 

    상세보기

97. 97. Shin HS Kim Y Kim G Lee JY Jeong I Joh JS . Immune responses to Middle East respiratory syndrome coronavirus during the acute and convalescent phases of human infection . Clin Infect Dis. ( 2019 ) 68 : 984 ？ 92 . 10.1093/cid/ciy595 30060038 

    상세보기

98. 98. Zuo Y Yalavarthi S Shi H Gockman K Zuo M Madison JA Neutrophil extracellular traps in COVID-19 . JCI Insight . ( 2020 ) 5 : e138999 10.1101/2020.04.30.20086736 

    

99. 99. Wang F Nie J Wang H Zhao Q Xiong Y Deng L . Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia . J Infect Dis. ( 2020 ) 221 : 1762 ？ 9 . 10.1093/infdis/jiaa150 32227123 

    상세보기

100. 100. Zheng M Gao Y Wang G Song G Liu S Sun D . Functional exhaustion of antiviral lymphocytes in COVID-19 patients . Cell Mol Immunol. ( 2020 ) 17 : 533 ？ 5 . 10.1038/s41423-020-0402-2 32203188 

     상세보기

101. 101. Xu Z Shi L Wang Y Zhang J Huang L Zhang C . Pathological findings of COVID-19 associated with acute respiratory distress syndrome . Lancet Respir Med . ( 2020 ) 8 : 420 ？ 22 . 10.1016/S2213-2600(20)30076-X 32085846 

     상세보기

102. 102. Liao M Liu Y Yuan J Wen Y Xu G Zhao J . Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 . Nat Med. ( 2020 ) 26 : 842 ？ 44 . 10.1038/s41591-020-0901-9 32398875 

     상세보기

103. 103. Wang C Xie J Zhao L . Aveolar Macrophage Activation and Cytokine Storm in the Pathogenesis of Severe COVID-19. Research Square PREPRINT (Version 1). 32574956 

104. 104. Zhang D Guo R Lei L Liu H Wang Y Wang Y COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcome . medRxiv [Preprint] . ( 2020 ). 10.1101/2020.03.24.20042655 

     

105. 105. Zhou Y Fu B Zheng X Wang D Zhao C Qi Y Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients . Natl Sci Rev . ( 2020 ) 7 : 998 ？ 1002 . 10.1093/nsr/nwaa041 

     상세보기

106. 106. Feng Z Diao B Wang R Wang G Wang C Tan Y The novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes . medRxiv [Preprint] . ( 2020 ). 10.1101/2020.03.27.20045427 

     

107. 107. Ziegler CGK Allon SJ Nyquist SK Mbano IM Miao VN Tzouanas CN . SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues . Cell. ( 2020 ) 181 : 1016 ？ 35 e19 . 10.1016/j.cell.2020.04.035 32413319 

     상세보기

108. 108. Wei L Ming S Zou B Wu Y Hong Z Li Z Viral Invasion and Type I Interferon Response Characterise the Immunophenotypes during COVID-19 Infection. SSRN ( 2020 ). 

109. 109. Zheng HY Zhang M Yang CX Zhang N Wang XC Yang XP . Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients . Cell Mol Immunol . ( 2020 ) 17 : 541 ？ 3 . 10.1038/s41423-020-0401-3 32203186 

     상세보기

110. 110. Chen N Zhou M Dong X Qu J Gong F Han Y . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study . Lancet. ( 2020 ) 395 : 507 ？ 13 . 10.1016/S0140-6736(20)30211-7 32007143 

     상세보기

111. 111. Ni L Ye F Cheng ML Feng Y Deng YQ Zhao H . Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals . Immunity . ( 2020 ) 52 : 971 ？ 7 .e3. 10.1016/j.immuni.2020.04.023 32413330 

     상세보기

112. 112. Thevarajan I Nguyen THO Koutsakos M . Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19 . Nat Med . ( 2020 ) 26 : 453 ？ 5 . 10.1038/s41591-020-0819-2 32284614 

     상세보기

113. 113. Wu D Yang XO . TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib . J Microbiol Immunol Infect . ( 2020 ) 53 : 368 ？ 70 . 10.1016/j.jmii.2020.03.005 32205092 

     상세보기

114. 114. Wu F Wang A Liu M Wang Q Chen J Xia S Neutralising antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications . medRxiv [Preprint] . ( 2020 ) 10.1101/2020.03.30.20047365 

     

115. 115. Zhao J Yuan Q Wang H Liu W Liao X Su Y Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 . Clin Infect Dis . ( 2020 ) ciaa344. 10.1101/2020.03.02.20030189 

     

116. 116. Chen Y Li L . SARS-CoV-2: virus dynamics and host response . Lancet Infect Dis . ( 2020 ) 20 : 515 ？ 16 . 10.1016/S1473-3099(20)30235-8 32213336 

     상세보기

117. 117. Sanders JM Monogue ML Jodlowski TZ Cutrell JB . Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review . JAMA . ( 2020 ) 323 : 1824 ？ 36 . 10.1001/jama.2020.6019 32282022 

     

118. 118. Jin Z Du X Xu Y Deng Y Liu M Zhao Y . Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors . Nature . ( 2020 ) 582 : 289 ？ 93 . 10.1038/s41586-020-2223-y 32272481 

     상세보기

119. 119. Tanaka T Narazaki M Kishimoto T . Immunotherapeutic implications of IL-6 blockade for cytokine storm . Immunotherapy. ( 2016 ) 8 : 959 ？ 70 . 10.2217/imt-2016-0020 27381687 

     상세보기

120. 120. Xu X Han M Li T Sun W Wang D Fu B . Effective treatment of severe COVID-19 patients with tocilizumab . Proc Natl Acad Sci USA . ( 2020 ) 117 : 10970 ？ 75 . 10.1073/pnas.2005615117 32350134 

     상세보기

121. 121. Fu B Xu X Wei H . Why tocilizumab could be an effective treatment for severe COVID-19? J Transl Med. ( 2020 ) 18 : 164 . 10.1186/s12967-020-02339-3 32290839 

     상세보기

122. 122. Maes B Bosteels C De Leeuw E Declercq J Van Damme K Delporte A Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial . Trials ( 2020 ) 21 : 468 10.1186/s13063-020-04453-5 32493441 

     상세보기

123. 123. Fuller MJ Callendret B Zhu B Freeman GJ Hasselschwert DL Satterfield W . Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1) . Proc Natl Acad Sci USA. ( 2013 ) 110 : 15001 ？ 6 . 10.1073/pnas.1312772110 23980172 

     상세보기

124. 124. Qin C Zhou L Hu Z Zhang S Yang S Tao Y . Dysregulation of immune response in patients with COVID-19 in Wuhan, China . Clin Infect Dis . ( 2020 ) 71 : 762 ？ 8 . 10.1093/cid/ciaa248 32161940 

     상세보기

125. 125. Zhang C Wang XM Li SR Twelkmeyer T Wang WH Zhang SY . NKG2A is a NK cell exhaustion checkpoint for HCV persistence . Nat Commun. ( 2019 ) 10 : 1507 . 10.1038/s41467-019-09212-y 30944315 

     상세보기

126. 126. Paul LM Carlin ER Jenkins MM Tan AL Barcellona CM Nicholson CO . Dengue virus antibodies enhance Zika virus infection . Clin Transl Immunology. ( 2016 ) 5 : e117 . 10.1038/cti.2016.72 28090318 

     상세보기

127. 127. Bardina SV Bunduc P Tripathi S Duehr J Frere JJ Brown JA . Enhancement of Zika virus pathogenesis by pre-existing antiflavivirus immunity . Science. ( 2017 ) 356 : 175 ？ 80 . 10.1126/science.aal4365 28360135 

     상세보기

128. 128. Argolo AF Feres VC Silveira LA Oliveira AC Pereira LA Junior JB . Prevalence and incidence of dengue virus and antibody placental transfer during late pregnancy in central Brazil . BMC Infect Dis. ( 2013 ) 13 : 254 . 10.1186/1471-2334-13-254 23725365 

     상세보기

129. 129. Zhao J Li K Wohlford-Lenane C Agnihothram SS Fett C Zhao J . Rapid generation of a mouse model for Middle East respiratory syndrome . Proc Natl Acad Sci USA. ( 2014 ) 111 : 4970 ？ 5 . 10.1073/pnas.1323279111 24599590 

     상세보기

130. 130. Yip MS Leung NH Cheung CY Li PH Lee HH Daeron M . Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus . Virol J. ( 2014 ) 11 : 82 . 10.1186/1743-422X-11-82 24885320 

     상세보기

131. 131. Sharma A . It is too soon to attribute ADE to COVID-19 . Microbes Infect. ( 2020 ) 22 : 158 . 10.1016/j.micinf.2020.03.005 32268188 

     상세보기

132. 132. Du L He Y Zhou Y Liu S Zheng BJ Jiang S . The spike protein of SARS-CoV？a target for vaccine and therapeutic development . Nat Rev Microbiol. ( 2009 ) 7 : 226 ？ 36 . 10.1038/nrmicro2090 19198616 

     상세보기

133. 133. Smith CC Entwistle S Willis C Vensko S Beck W Garness J . Landscape and selection of vaccine epitopes in SARS-CoV-2 . bioRxiv [Preprint] . ( 2020 ). 10.1101/2020.06.04.135004 32577654